Reva Basho

Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer

Reva Basho, Michael Z. Gilcrease, Rashmi K. Murthy et al. · JAMA Oncology · 2016 · 187 citations

Medicine, Oncology, Pharmacology +17

Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer

Stephen L. Shiao, Kenneth Gouin, Nathan Ing et al. · Cancer Cell · 2024 · 164 citations

Medicine, Oncology, Radiation Oncology +17

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

Jennifer K. Litton, Meredith M. Regan, Lajos Pusztai et al. · Journal of Clinical Oncology · 2023 · 100 citations · Full text

Medicine, Oncology, Breast Oncology +16

Evaluating the impact of age on immune checkpoint therapy biomarkers

Rossin Erbe, Zheyu Wang, Sharon Wu et al. · Cell Reports · 2021 · 80 citations · Full text

Medicine, Immunology, Oncology +17

Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer

Funda Meric‐Bernstam, Xiaofeng Zheng, Maryam Shariati et al. · JCO Precision Oncology · 2018 · 62 citations · Full text

Medicine, Genetics, Oncology +17